KIR3DL2 and rheumatoid arthritis: Engagement of KIR3DL2 by B*272 promotes the survival of KIR3DL2+ NK cells, and peripheral blood NK cells from SpA patients showed higher cytotoxicity than those from RA patients and healthy controls (88).